# Preventing Sexual Dysfunction With Aromatase Inhibitors

> **NCT01603303** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 187 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BEHAVIORAL:** Questionnaires
- **OTHER:** Education Materials
- **OTHER:** Luvena
- **OTHER:** Hyalo-Gyn
- **OTHER:** Vaginal Lubricant
- **BEHAVIORAL:** Interactive Internet-Based Website
- **BEHAVIORAL:** Telephone Counseling.

## Key facts

- **NCT ID:** NCT01603303
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-05
- **Primary completion:** 2017-08-11
- **Final completion:** 2017-08-11
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2017-08-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603303, "Preventing Sexual Dysfunction With Aromatase Inhibitors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01603303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*